Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Angiotensin-converting enzyme-1 gene insertion/deletion polymorphism may be associated with COVID-19 clinical severity: a prospective cohort study.

Annals of Saudi medicine - 1 Jan 2000

Gunal Ozgur, Sezer Ozlem, Ustun Goksenin Unluguzel, Ozturk Cagatay Erman, Sen Ahmet, Yigit Serbulent, Demirag Mehmet Derya

Abstract excerpt

BACKGROUND: Angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism may play a role in the pathogenesis of coronavirus-19 disease (COVID-19). OBJECTIVES: Investigate the relationship between ACE I/D polymorphism and the clinical severity of COVID-19. DESIGN: Prospective cohort study. SETTING: Tertiary care hospital. PATIENTS AND METHODS: The study included COVID-19 patients with asymptomatic,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genotyping Techniques

Share to Mutagenesis, Insertional

Share to Peptidyl-Dipeptidase A

Share to Sequence Deletion

Share to Severity of Illness Index

Source

Open in PubMed Open full text

Identifiers

PMID: 34085542
DOI: 10.5144/0256-4947.2021.141
PMCID: PMC8176375

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Angiotensin-converting enzyme-1 gene insertion/deletion polymorphism may be associated with COVID-19 clinical severity: a prospective cohort study.PMID 34085542Read ↗

Insertion/deletion (I/D) polymorphisms of angiotensin-converting enzyme gene and their implications for susceptibility and severity of COVID-19: A systematic review and meta-analysisSemantic proximity Read ↗

Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19Semantic proximity Read ↗

Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients.Semantic proximity Read ↗

Angiotensin-converting-enzyme insertion/deletion polymorphism, ACE activity, and COVID-19: A rather controversial hypothesis. A case-control study.Semantic proximity Read ↗

The Role of Angiotensin Converting Enzyme 1 Insertion/Deletion Genetic Polymorphism in the Risk and Severity of COVID-19 InfectionSemantic proximity Read ↗

Role of ACE, ACE2 gene variants and serum ACE/ACE2 ratio in COVID-19 severitySemantic proximity Read ↗

An Updated Review on the Role of Single Nucleotide Polymorphisms in COVID-19 Disease Severity: A Global Aspect.Semantic proximity Read ↗

Role of ACE2 and TMPRSS2 polymorphisms on COVID-19 outcome and disease severity in adult patients: A prospective cohort study in a tertiary hospital, Indonesia.Semantic proximity Read ↗

Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease MortalitySemantic proximity Read ↗

The effect of angiotensin-converting enzyme insertion/deletion polymorphism on severity and death rate of COVID-19 in Iranian patientsSemantic proximity Read ↗

The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and TherapySemantic proximity Read ↗

Angiotensin-converting enzyme (<i>ACE1, ACE2</i>) gene variants are associated with COVID19 severity depending on the hypertension statusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.